Streetbeat News

Regulatory

EPOW

Sunrise New Energy Co., Ltd. has regained compliance with Nasdaq's minimum bid price requirement. The company was previously notified by Nasdaq for not meeting the $1.00 minimum bid price, but has now met the requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:28 pm

AZN

AstraZeneca is under investigation by Chinese authorities for potential data privacy breaches and unlicensed drug importation. CEO Pascal Soriot assures compliance and cooperation. Meanwhile, AstraZeneca's lung cancer drug trial shows promising but not statistically significant results.

Portfolio Pulse from Vandana Singh

September 10, 2024 | 1:19 pm

AAPL

The European Court of Justice (ECJ) has overturned a 2020 judgment, confirming the European Commission's 2016 state aid decision against Apple. As a result, Apple expects to incur a one-time income tax charge of up to $10 billion in Q4, impacting its effective tax rate.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:13 pm

ISSC

Innovative Solutions & Support (IS&S) has received FAA approval for its digital Engine-Indicating and Crew-Alerting System (EICAS) Display System, enhancing its B757/B767 Flat Panel Display System. This upgrade addresses CRT obsolescence, reduces weight, and improves fuel efficiency.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:06 pm

JPM

XOM

JP Morgan CEO Jamie Dimon stated that the bank would not have acquired First Republic without government backing. He emphasized the need for rational policies to tackle climate issues and finance energy transitions, highlighting the importance of financing companies like Exxon and providing LNG to allies.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 1:05 pm

ZAPP

Zapp EV has completed homologation with Thailand's Department of Land Transportation, allowing it to sell its i300 electric urban motorcycle in the country. This marks a significant step for Zapp EV in expanding its market presence.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:47 pm

ATOS

Atossa Therapeutics supports the FDA's new rule requiring mammography facilities to inform patients about breast density, which is crucial for breast cancer detection. This aligns with Atossa's focus on breast cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:31 pm

CRVS

Corvus Pharmaceuticals has initiated a Phase 3 clinical trial for soquelitinib, a potential first-in-class ITK inhibitor, targeting relapsed/refractory peripheral T-cell lymphoma. The drug has received Orphan Drug and Fast Track Designations from the FDA.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:30 pm

RLYB

Rallybio Corporation (NASDAQ:RLYB) will present findings from an epidemiological analysis on FNAIT risk across diverse populations at the NORD Breakthrough Summit. This highlights their focus on rare diseases and potential advancements in therapies.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 12:21 pm

CRWD

MSFT

Microsoft is hosting a cybersecurity summit in response to a global IT outage caused by a faulty software update from CrowdStrike, affecting 8.5 million devices. The summit aims to address security issues and reconsider Microsoft's security frameworks.

Portfolio Pulse from Benzinga Neuro

September 10, 2024 | 12:16 pm